Irish MedTech Company Medihive Receives €7 Million Investment

Irish MedTech Company Medihive Receives €7 Million InvestmentThe business is now valued at €62 million following the investment. Medihive includes Ireland’s largest online doctor service WebDoctor.ie. The investment will be used to fuel international growth, drive R&D innovation and accelerate healthcare software developments. Medihive will recruit up to 42 key hires across sales, engineering, doctors and marketing departments, adding to the 130 people already working with the company.

Medihive, Ireland’s award-winning health technology platform, which includes Webdoctor.ie, has secured an investment from ResMed, an international leader in digital health and cloud-connected medical device innovation, as well as existing shareholders including VentureWave Capital. The investment now values the business at €62 million.

Medihive is a software company built to transform medical processes that don’t work so patients can benefit from healthcare that does work. The business provides sophisticated software and clinical solutions to the healthcare, pharmacy and insurance industries, as well as direct to consumers and corporates via www.webdoctor.ie. The company combines digital and clinical know-how to bring clients and their end users high-quality virtual care on a global scale. 

The €7 million investment announced today will be used to further increase the international growth of the business, drive investment and innovation in R&D and accelerate healthcare software developments. The company currently employs 130 people and it is expected this number will now increase by a further 42 employees over the next two years.

ResMed, whose cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases, enabling people to live healthier lives, has been working with Medihive since 2019 and now joins as an investor. ResMed Germany led deal negotiations on behalf of the organisation. As a result of their investment, ResMed will now take a seat on the board to work with the team to accelerate the growth of the business. 

Meanwhile, existing shareholders in Medihive have invested additional capital into the business. This follows the €3 million investment in August 2021 by VentureWave Capital, the private equity firm that focuses on entrepreneurial companies that make a positive social impact, are in vital sectors and address UN Sustainable Development Goals. At the time of VentureWave Capital’s €3 million in August 2021, the business was valued at €48 million. Today’s investment now values the company at €62 million, a significant 29% increase.

Noel McSweeney, Chairman of Medihive, said: “The investment from ResMed alongside the increased support from current shareholders demonstrates our shared passion for medical technology advancement and will allow Medihive and Webdoctor.ie to further expand and develop our services while continuing to provide transformative digital healthcare solutions.”

Katrin Pucknat, President of ResMed Germany, said: “At ResMed, our mission is to change 250 million lives in 2025 in out-of-hospital care settings, and today’s announcement fits perfectly with that goal. Our work to date with Medihive has transformed the lives of our patients by making their care pathway less disjointed and allowing them to get diagnosed for sleep apnea outside of a hospital setting. ResMed places significant importance on innovation and this investment will enable both organisations to continue to be at the forefront of developments in healthcare technology. We look forward to supporting the team at Medihive as part of their board and believe this relationship will create new opportunities for us both while continuing to transform the healthcare industry.”

David Crimmins, CEO of MediHive, said: “Medihive builds solutions to deliver positive patient outcomes by removing friction from their care journeys. This investment now comes at a pivotal moment for Medihive. Over the last two and a half years, demand for our services has surged as organisations realised they can achieve better patient outcomes by blending smart health technology with their traditional health infrastructures. This investment will enable us to continue meeting this demand while also allowing us to scale and expand our services in the continually evolving telehealth market both in Ireland and internationally. It’s an exciting time for Medihive, and we’re really looking forward to working with ResMed and our current shareholders to continue to make advances and improvements in digital healthcare for patients and professionals in the industry alike.”

Alan Foy, Chairman and Managing Partner VentureWave Capital, said: “We are delighted to once again invest in Medihive alongside ResMed, a key strategic investor. As a successful Irish health technology business that’s making an impact on delivering digital health and patient outcomes, this investment demonstrates our continued support and confidence in Medihive’s business goals, global impact and strategic ambitions.“

                       Inspiring a world where instant, frictionless access to healthcare is the norm.

                                                             Medihive, Welcome Tomorrow.

For more information, visit www.medihive.com

Contact Information:

Breda Brown

PR Director

[email protected]

087 2487120

Viv Murphy

PR Senior Account Manager

[email protected]

0876160846

Related Files
Authorization_Form.pdf

Related Images

Original Source:

Irish MedTech Company Medihive Receives €7 Million Investment

Astrologer Pt Umesh Chandra Pant to Transform People’s Lives With His New Website AstrologerUmesh

Astrologer Pt Umesh Chandra Pant to Transform People’s Lives With His New Website AstrologerUmeshPt. Umesh Chandra Pant – A learned and Best Vedic Astrologer in India

Astrologer Pt Umesh Chandra Pant to Transform People’s Lives With His New Website AstrologerUmesh
Best Astrologer In Delhi

Pt Umesh Chandra Pant, for the last 22 years, his organization has earned a very good name among the people with its good astrological work. For which they are always striving. They always assure very good astrological advice.

Astrologer Pt. Umesh Chandra Pant, a man who specializes in Vedic astrology and Vastu Shastra feels pleased to share the thought of his ambitious website, AstrologerUmesh dot com, for people looking for high-quality and affordable services in astrology.

The officially released website houses a comprehensive suite of astrological services and solutions dedicated to helping people with quality and time-bound solutions in Vedic astrology. 

Besides, it also features an exclusive series of services, ranging from astrological reports, horoscope reading, Puja, Anusthan and guidance to remedies, along with his insights into the field of astrology, spirituality and divinity.

Fondly known as the Best Vedic Astrologer in India, Pt. Umesh Chandra Pant was born and raised in a Brahmin family based in Delhi. He has 22+ years of experience in serving people through a unique astrological approach, uplifting their lives with peace and prosperity. He thinks that people who have subscribed to the notion of astrology undoubtedly believe in its boundless power. 

According to him, his website is able to help people with curative measures for problems in various aspects of their life, such as marriage, career, business, academic pursuit, and helps them find solutions keeping in alignment with their life’s goals and purposes. He believes that it will help people transform their life positively.

Astrologer Pt. Umesh Chandra Pant believes that astrology is one of the most powerful techniques for analyzing planetary positions and making adjustments accordingly in people’s lives, helping them find peace, happiness, joy, or a solution to penury. However, he makes a fine point in saying that astrology works when it is trusted with unconditional faith. 

“Astrology is more like a relationship that requires trust to keep it working for long. No astrological remedy will ever work if you don’t show at least a certain degree of trust in astrology,” he says when he was asked about whether astrology should be trusted for solutions to problems that people face in their day to day life.

Pt. Umesh Chandra Pant – A Seasoned Astrologer

Astrologer Pt. Umesh Chandra Pant is a seasoned astrologer who decodes planetary subtlety behind the genesis of problems or hardships in the life of people. His astrological solutions work in people’s favor, helping them find a new meaning in life or feel motivated with a renewed sense of energy. He attributes his knowledge and experience in astrology to the grace and generosity of God. That’s why he has also got a place in India’s Top 10 Astrologers And Vastu Consultants of the year 2022. 

He says, “I think it is because of the kindness and blessings of the Divine Almighty that I am able to serve people as efficiently as I could. I offer my humble prayers to God for gifting me the ability to heal the problems of people and help them find success in their chosen field of activity.”

He is also one of the biggest proponents of the maxim ‘Vasudhaiva Kutumbakam’ (The world is one family) and tries his best to uphold it in his astrological practice.

For more information about Astrologer Umesh, visit his website. Click: AstrologerUmesh

Contact Information:

Pt Umesh Chandra Pant

Founder and Chief Astrologer

[email protected]

+91 9910582401

Related Files
Astrologer-Pt-Umesh-Umesh-Chandra-Pant.pdf
Astrologer-Umesh-Image.jpg

Original Source:

Astrologer Pt Umesh Chandra Pant to Transform People’s Lives With His New Website AstrologerUmesh

Oculogica Publishes 5-Site Study on Its FDA-Cleared Concussion Diagnostic

Oculogica Publishes 5-Site Study on Its FDA-Cleared Concussion Diagnostic

Oculogica Inc. announces publication of the initial five-site study performed to obtain FDA Marketing Authorization for its EyeBOX technology as an aid in the diagnosis of concussion. EyeBOX uses eye tracking to assess pupil size and position to determine whether a person has sustained damage to brain regions that control those functions.

The study, published in Frontiers in Neurology Dec. 1, 2022, was performed on 282 emergency room or concussion clinic patients ages 5 to 67 within two weeks of injury. Study participants were evaluated at New York City’s Bellevue Hospital, Rochester’s Mayo Clinic, Pittsburgh’s Allegheny Hospital, Denver’s Rocky Mountain Hospital for Children, and Beaver Dam Wisconsin’s Community Hospital.

The study demonstrated that patients who had symptoms of concussion and scored poorly on a cognition assessment were more likely to have abnormal eye tracking, as assessed by the technology’s proprietary BOX (Brain injury associated Ocular motility dysfunction) Score. The BOX Score diagnosed concussion with over 80% sensitivity.

“The brain has tremendous heterogeneity of normal baseline function. This makes it challenging to figure out normal versus abnormal function when injury occurs. Assessment of pupil size and movement can be a powerful way to assess function because the majority of people have relatively normal function that is controlled reflexively. A person cannot pretend to have pupils that constrict normally and move in a synchronized way when they do not,” said neurosurgeon Uzma Samadani, MD, Ph.D., and Oculogica founder. “Similarly, if their brain and therefore pupil function is normal, it is difficult to pretend that it is not. Eye tracking to assess pupil size and position is a truly objective measure of physiologic brain function. We consider it a form of more precise digital neurologic examination. We believe that this will eventually and inevitably become standard of care.”

“We decided to publish this data because so many people have asked us what the gold-standard for concussion is, and how one obtains FDA approval for a concussion diagnostic,” said Oculogica CEO Rosina Samadani, Ph.D. “The reality is that there is currently no single gold-standard, and that is one of the challenges of any study in the field. We found that those with the worst symptoms and poorest cognition were most likely to have an elevated BOX score. Fundamentally, if a patient has abnormal eye reflexes or movement, that is their objective physiologic condition, regardless of symptom severity or ability to perform on a cognitive test. This information is helpful when people may under or over-report symptoms or have high or low baseline cognitive skills. It also may reduce biases due to language, culture, education or other factors that impact traditional patient assessment.”

The EyeBOX technology is the first non-invasive, non-baseline requiring concussion diagnostic approved by the FDA for aid in the diagnosis of concussion. Leading clinics, such as the Mayo Clinic, Midwest Orthopedics at Rush University and Minneapolis Clinic of Neurology, amongst others, offer the technology.

Contact Information:

Cady Roedl

Customer Success Manager

[email protected]

9205173873

Original Source:

Oculogica Publishes 5-Site Study on Its FDA-Cleared Concussion Diagnostic